HOME Research Insight BD (US) and Medtronic (US) are the Largest Player in the Blood Collection Market



BD (US) and Medtronic (US) are the Largest Player in the Blood Collection Market


The global blood collection market is estimated to account for USD 8.10 Billion in 2017 and is expected to grow at a CAGR of 5.5% to reach USD 10.59 Billion by 2022. The increasing prevalence of diseases, growing number of accidental & trauma cases, and rising number of surgeries are fueling the growth of the blood collection market. However, high cost associated with automated blood collection devices is restraining the growth of this market.

Product launches and approvals were the dominant strategies adopted by key players to sustain their positon in the market. Becton, Dickinson and Company (US), Terumo (Japan), Greiner Holding (Austria), and Haemonetics (US) are some of companies who adopted these strategies to enhance their share in the market.

BD (US) is the largest player in the global blood collection market. The company offers a wide range of products in the blood collection market including blood collection tubes, blood collection needles and syringes, blood bag set, and blood lancets. With its strong geographic presence and extensive product portfolio, the company is expected to witness a strong growth in the blood collection market during the forecast period. The company focuses on organic strategies to maintain its position in the market.

Medtronic (US) is another leading player operating in the blood collection market. The company offers an extensive portfolio under the global brand name Monoject. The company focuses on strategies like expansions and acquisitions to strengthen and expand its presence in the market. For instance, in 2016, Medtronic established its new Asia Pacific regional headquarter in Singapore. This expansion enabled the company to strengthen its presence in the APAC market.

Terumo (Japan), a leading company that offers a broad range of blood collection products especially apheresis systems. The company geographically operates in the Americas, Europe, and Asia with major revenue coming from the Americas. The company focuses mainly on product approvals to maintain its position in the market. For instance, in 2017, the company received CE marked for its apheresis device Spectra Optia system, which is the first and only approved device of the company in the market today to treat Guillain-Barré syndrome (GBS) and myasthenia gravis (MG) by therapeutic plasma exchange (TPE).

Some of the other players competing in this market are Fresenius (Germany), Nipro Medical (US), F.L. Medical (Italy), Smiths Medical (US), Grifols (Spain), Kawasumi Laboratories (Japan), and Quest Diagnostics (US).

Related Reports:

Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports